Neo-Angin (Amylmetacresol, Levomenthol, 2,4 Dichlorobenzyl Alcohol)

Amylmetacresol and 2,4‑dichlorobenzyl alcohol act by disrupting bacterial and viral cell membranes, providing rapid antiseptic action. Levomenthol activates TRPM8 receptors on sensory nerves, creating a cooling sensation and mild analgesia that eases throat pain.

The dosage of Neo‑Angin is determined by the prescribing healthcare professional. Typically, the prescriber advises the number of lozenges to dissolve slowly in the mouth at specified intervals, based on the severity of symptoms and patient age.

Safety data for Neo‑Angin in pregnancy and lactation are limited. Women who are pregnant or breastfeeding should consult their physician before using the product to weigh potential benefits against unknown risks.

To order Neo‑Angin, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with simple menthol lozenges, Neo‑Angin combines antiseptic agents (amylmetacresol and 2,4‑dichlorobenzyl alcohol) with a cooling anesthetic, offering both antimicrobial activity and symptomatic relief. This dual action can be advantageous for mild infections, whereas plain menthol lozenges provide only analgesic effects.

Store Neo‑Angin at ambient temperature, preferably below 25 °C. Keep the lozenges in their original packaging, protect them from moisture, direct sunlight and excessive heat to maintain potency and prevent degradation.

Neo‑Angin is intended for oromucosal use. The lozenge should be placed in the mouth and allowed to dissolve slowly, without chewing, to ensure even distribution of the active ingredients across the throat and oral mucosa.

Serious risks, although rare, include allergic reactions such as rash, swelling, hives, or anaphylaxis, and severe oral ulceration. If any signs of a systemic allergic response appear, discontinue use immediately and seek medical attention.

Neo‑Angin should be avoided by individuals with known hypersensitivity to amylmetacresol, levomenthol, 2,4‑dichlorobenzyl alcohol, or any excipients in the formulation, as well as children younger than six years unless directed by a healthcare professional.